New gene-altering treatment offered for certain blood cancers | The Source | Washington University in St. Louis
A new immunotherapy that targets certain blood cancers is being offered for the first time at Siteman Cancer Center. Newly approved by the FDA for types of advanced non-Hodgkin lymphoma in adults, the CAR-T cell therapy harnesses a patient’s own immune system to fight cancer.